Drug factory · FDA FEI 3000719749

Biogen MA Inc.

5000 Davis Drive, Morrisville, NC, United States

United States: 1

No problems found at FDA's last inspection, Jun 13, 2018.

No Action Indicated: inspectors found no objectionable conditions.

9 drug inspections on record since 2009: 6 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AmivantamabMakes the active ingredient and tests it Janssen Biotech, Inc. 57894-501
DaratumumabMakes the active ingredient Janssen Biotech, Inc. 57894-502
Efanesoctocog AlfaMakes the active ingredient Bioverativ Therapeutics Inc. 71104-978, 71104-979, 71104-981 +3
Efmoroctocog AlfaMakes the active ingredient and tests it Bioverativ Therapeutics Inc. 71104-801, 71104-802, 71104-803 +7
Eftrenonacog AlfaMakes the active ingredient and tests it Bioverativ Therapeutics Inc. 71104-911, 71104-922, 71104-933 +3
GuselkumabMakes the active ingredient Janssen Biotech, Inc. 57894-640, 57894-650, 57894-651
SutimlimabMakes the active ingredient and tests it Bioverativ Therapeutics Inc. 80203-347
TalquetamabMakes the active ingredient and tests it Janssen Biotech, Inc. 57894-469, 57894-470
TeclistamabMakes the active ingredient and tests it Janssen Biotech, Inc. 57894-449, 57894-450
TocilizumabMakes the active ingredient and tests it Biogen MA Inc. 64406-022, 64406-023

FDA inspection history

EndedResultProgramProblems noted
Jun 13, 2018No problems foundDrug Quality Assurance—
Jan 15, 2016No problems foundDrug Quality Assurance—
Jun 19, 2015No problems foundDrug Quality Assurance—
Nov 14, 2014Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 2, 2013No problems foundBioresearch Monitoring—
Aug 2, 2013Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 30, 2011Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 25, 2009No problems foundDrug Quality Assurance—
Jan 29, 2009No problems foundBioresearch Monitoring—

Registered with FDA for: analysis; api manufacture.